Susanne Schaffert

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susanne Schaffert:

Form 4 holding Director

Rubius Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
50,000
Estimated value
Report date
29 Jul 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

INCYTE CORP

Security class
Non Qualfied Stock Option (right to buy)
Shares / value
9,216
Estimated value
Report date
10 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Susanne Schaffert

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .